SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE520.80-11.2 (-2.11 %)
PREV CLOSE ( ) 532.00
OPEN PRICE ( ) 533.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 376414
TODAY'S LOW / HIGH ( )519.00 536.35
52 WK LOW / HIGH ( )315.2 550.7
NSE520.80-11.35 (-2.13 %)
PREV CLOSE( ) 532.15
OPEN PRICE ( ) 532.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 520.80 (644)
VOLUME 8730794
TODAY'S LOW / HIGH( ) 519.05 535.95
52 WK LOW / HIGH ( )312 550.8
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
13Aug Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that the exchange has receive..
05Aug TCS, Sun Pharmaceutical and NMDC to se
Digitate, a software venture of Tata Consultancy Services (TCS) has laun..
05Aug Sun Pharma rises on launching FluGuard
Sun Pharmaceutical Industries is currently trading at Rs. 532.50, up by..
04Aug Sun Pharma launches FluGuard in India
Sun Pharmaceutical Industries has launched FluGuard (Favipiravir 200 mg)..
03Aug Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that it has enclosed Newspape..
Financials
Rs. in Millions
QTR Jun 20 ANNUAL 20
Net Profit5319.532111.4
Gross Profit 5315.2 32530
Operating Profit 7432.142225.7
Net Sales 29630.4125319.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 2906.70 (4.25%)
M.Cap (Rs. in Cr)34753.96
NGL Fine-Chem (BSE)
 589.85 (20.00%)
M.Cap (Rs. in Cr)364.41
Glaxosmithkline Phar (BSE)
 1523.60 (4.51%)
M.Cap (Rs. in Cr)25810.70
Aarti Drugs (BSE)
 2139.65 (3.16%)
M.Cap (Rs. in Cr)4985.38
Caplin Point Lab (BSE)
 556.80 (9.10%)
M.Cap (Rs. in Cr)4211.79
Shareholding Pattern
PROMOTERS 54.69%
NON-INSTITUTION 12.5%
MUTUAL FUNDS/UTI 10.52%
FI/BANKS/INSURANCE 9.38%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Sanjay Jadli, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

For Lodge the grievances click on https://scores.gov.in

Click/visit on SEBI Complaints Redress System (SCORES) for Procedure for filing of complaints on SCORES and benefits.

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.